Suven Life Sciences Q2 flat at Rs 25 cr

Drug firm Suven Life Sciences today reported a marginal decline in standalone net profit to Rs 24.72 crore for the second quarter ended September 30.

The company had posted a net profit of Rs 24.83 crore for the July-September period of the previous fiscal, Suven Life Sciences said in a regulatory filing.

Standalone net sales during the quarter under review was also down 16.49% to Rs 116.76 crore as against Rs 139.83 crore in the year-ago period.

Shares of the company were trading at Rs 263.10 on BSE at 13:50 hrs, down 0.45%.